• FindZebra
  • About
  • Contact
  • Help
  • Login
Advanced
  • Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency OMIM
    Patients with PNPO mutations tend to respond better to treatment with pyridoxal 5-prime phosphate (PLP) than with pyridoxine (summary by Plecko et al., 2014). Clinical Features Brautigam et al. (2002) described twins, born of first-cousin parents, who were born at 29 weeks' gestation and suffered from birth from severe convulsions, myoclonus, rotatory eye movements, sudden clonic contractions, burst suppression electroencephalogram (EEG), hypoglycemia, and acidosis. ... Biochemical abnormalities in CSF and urine were as for AADC deficiency with the additional features of raised glycine (in all 5), threonine (4 of 5), taurine (4 of 5), histidine (all 5), and low arginine (3 of 5). ... INHERITANCE - Autosomal recessive GROWTH Other - Failure to thrive HEAD & NECK Head - Microcephaly, progressive Eyes - Eye movement abnormalities ABDOMEN Gastrointestinal - Feeding problems NEUROLOGIC Central Nervous System - Neonatal epileptic encephalopathy (NEE) - Global developmental delay, variable severity - Burst suppression on EEG - Seizures - Myoclonus - Partial response to pyridoxine - Response to pyridoxal phosphate - Hypotonia, truncal - Hypertonia - Unsteady gait METABOLIC FEATURES - Metabolic acidosis HEMATOLOGY - Anemia PRENATAL MANIFESTATIONS Delivery - Preterm delivery - Low APGAR scores LABORATORY ABNORMALITIES - Increased blood lactate - Hypoglycemia - Normal to increased plasma glycine - Normal to increased plasma threonine - Decreased plasma arginine - Increased urine vanillactic acid (VLA) - Decreased CSF homovanillic acid (HVA) - Decreased CSF 5-hydroxyindoleacetic acid (5HIAA) - Increased CSF 3-methoxytyrosine (3-MT) - Increased CSF glycine - Increased CSF threonine - Increased CSF taurine - Increased CSF histidine - Decreased CSF arginine - Decreased CSF pyridoxal 5-prime-phosphate (PLP) MISCELLANEOUS - Onset 0-12 hours after birth - Variable features and severity MOLECULAR BASIS - Caused by mutation in the pyridoxamine 5-prime-phosphate oxidase gene (PNPO, 603287.0001 ) ▲ Close
    PNPO, PLP1, PTHLH, PRDX5, PDXP
    • Pyridoxal 5'-Phosphate-Dependent Epilepsy GARD
      Pyridoxal 5'-phosphate-dependent epilepsy is a rare genetic metabolic disorder. Babies born with this disorder are not able to make enough Vitamin B6 and this causes the baby to start having seizures soon after they are born (also called early onset or neonatal onset seizures). The normal drugs to treat seizures ( anti-seizure medications or anti-convulsants) do not work for these babies, however seizures can be controlled by pyridoxal 5'-phosphate (the active form of Vitamin B6). Published studies in 2015 have shown that some babies with pyridoxal 5'-phosphate-dependent epilepsy also respond well to pyridoxene (a different form of Vitamin B6). Pyridoxal 5'-phosphate-dependent epilepsy is caused by changes or mutations in the PNPO gene and is inherited in an autosomal recessive manner.
    • Pyridoxal 5'-Phosphate-Dependent Epilepsy MedlinePlus
      Pyridoxal 5'-phosphate-dependent epilepsy is a condition that involves seizures beginning soon after birth or, in some cases, before birth. The seizures typically involve irregular involuntary muscle contractions (myoclonus), abnormal eye movements, and convulsions. Most babies with this condition are born prematurely and may have a temporary, potentially toxic, increase in lactic acid in the blood (lactic acidosis). Additionally, some infants have a slow heart rate and a lack of oxygen during delivery (fetal distress). Anticonvulsant drugs, which are usually given to control seizures, are ineffective in people with pyridoxal 5'-phosphate-dependent epilepsy.
    • Pyridoxal Phosphate-Responsive Seizures Orphanet
      Pyridoxal phosphate-responsive seizures is a very rare neonatal epileptic encephalopathy disorder characterized clinically by onset of severe seizures within hours of birth that are not responsive to anticonvulsants, but are responsive to treatment with pyridoxal phosphate.
  • Cerebellar Atrophy With Seizures And Variable Developmental Delay OMIM
    ., 2019), suggesting significant clinical variability of this disorder. Clinical Features Edvardson et al. (2013) reported 3 sibs, born of consanguineous Arab-Palestinian parents, with early infantile epileptic encephalopathy, global developmental delay, and cerebellar atrophy. ... EEG was consistent with epileptic encephalopathy and later evolved to slow background with multifocal spike and slow-wave discharges. Additional features included brisk reflexes and choreiform movements. ... Brain imaging showed cerebellar atrophy; dysmorphic features were not noted. Clinical Variability Valence et al. (2019) reported a 20-year-old man (P12), born of consanguineous Portuguese parents, with cerebellar ataxia. ... INHERITANCE - Autosomal recessive HEAD & NECK Face - Dysmorphic facial features (1 patient) Eyes - Abnormal eye movements - Nystagmus - Strabismus - Poor eye contact MUSCLE, SOFT TISSUES - Axial hypotonia - Peripheral hypertonia NEUROLOGIC Central Nervous System - Epileptic encephalopathy (in most patients) - Global developmental delay (in most patients) - Inability to walk (in most patients) - Seizures, refractory, early-onset - Multifocal discharges seen on EEG - Background slowing seen on EEG - Photoparoxysmal response seen on EEG - Ataxic gait - Ataxia - Dysmetria - Dysarthria - Choreiform movements - Dyskinetic movements - Cerebellar vermis atrophy MISCELLANEOUS - Onset in infancy - Variable severity - One patient with only a single seizure and normal cognitive development has been reported MOLECULAR BASIS - Caused by mutation in the calcium channel, voltage-dependent, alpha-2/delta subunit 2 gene (CACNA2D2, 607082.0001 ) ▲ Close
  • Corneal Dystrophy, Posterior Amorphous OMIM
    A number sign (#) is used with this entry because posterior amorphous corneal dystrophy (PACD) is a chromosome 12q21.33 contiguous gene deletion syndrome. Clinical Features Carpel et al. (1977) observed a posterior corneal dystrophy characterized by irregular sheetlike areas of opacification with involvement of the Descemet membrane and, in some instances, alterations of the normal endothelial mosaic. ... Family members manifested this rare abnormality in both its centroperipheral and peripheral forms. Additional features found in these patients included hyperopia, flattened corneal topography, anterior iris surface and stromal abnormalities, fine iris processes extending to the Schwalbe line for 350 degrees, and extension of the opacity to the limbus. ... Reexamination at 1 year of age showed a decrease in the stromal haze and sharper delineation of the posterior sheetlike opacity, and there was an increase in his hypermetropia to +7.5D bilaterally. Other features in the boy included left intraventricular hemorrhage at 5 days of life with midline shift and ventricular enlargement, for which he underwent placement of ventriculoperitoneal shunts due to progressive hydrocephalus. ... In addition, Kim et al. (2014) noted that loss-of-function mouse models involving the Lum and Kera genes showed phenotypic features consistent with those observed in the PACD families.
    EPYC, KERA, DCN, LUM
    • Posterior Amorphous Corneal Dystrophy Orphanet
      Posterior amorphous corneal dystrophy (PACD) is a very rare form of stromal corneal dystrophy (see this term) characterized by irregular amorphous sheet-like opacities in the posterior corneal stroma and in Descemet membrane and mildly impaired vision. Epidemiology Prevalence of this form of corneal dystrophy is not known. To date cases have been reported primarily in the USA. Clinical description Patients usually develop corneal abnormalities in infancy or childhood. The condition is non-progressive or slowly progressive. Visual acuity is usually only minimally affected but in some more severe cases, penetrating keratoplasty (PK) may be warranted. Unlike other corneal dystrophies, non-corneal manifestations have been observed and include abnormalities of the iris (iridocorneal adhesions, corectopia, and pseudopolycoria).
    • Posterior Amorphous Corneal Dystrophy Wikipedia
      Human disease Posterior amorphous corneal dystrophy Specialty Ophthalmology Posterior amorphous corneal dystrophy (PACD) is a rare form of corneal dystrophy . It is not yet linked to any chromosomal locus. The first report describing this dystrophy dates back to 1977. [1] References [ edit ] ^ Carpel EF, Sigelman RJ, Doughman DJ (May 1977). "Posterior amorphous corneal dystrophy". Am. J. Ophthalmol. 83 (5): 629–32. doi : 10.1016/0002-9394(77)90127-1 . PMID 301356 . External links [ edit ] Classification D OMIM : 612868 MeSH : C567546 C567546, C567546 v t e Types of corneal dystrophy Epithelial and subepithelial Epithelial basement membrane dystrophy Gelatinous drop-like corneal dystrophy Lisch epithelial corneal dystrophy Meesmann corneal dystrophy Subepithelial mucinous corneal dystrophy Bowman's membrane Reis–Bucklers corneal dystrophy Thiel-Behnke dystrophy Stroma Congenital stromal corneal dystrophy Fleck corneal dystrophy Granular corneal dystrophy Lattice corneal dystrophy Macular corneal dystrophy Posterior amorphous corneal dystrophy Schnyder crystalline corneal dystrophy Descemet's membrane and endothelial Congenital hereditary endothelial dystrophy Fuchs' dystrophy Posterior polymorphous corneal dystrophy X-linked endothelial corneal dystrophy This article about the eye is a stub . You can help Wikipedia by expanding it . v t e
  • Pierson Syndrome OMIM
    Mutations in the LAMB2 gene also cause nephrotic syndrome type 5 with or without mild ocular anomalies (NPHS5; 614199). Clinical Features Pierson et al. (1963) reported 2 sisters with congenital nephrotic syndrome and peculiar eye abnormalities. The renal disorder manifested in the newborn period with severe nephrotic syndrome followed by early-onset end-stage renal disease; both sisters died in the first 2 weeks of life. Ocular features included extreme nonreactive narrowing of the pupils (microcoria) due to aplasia or atrophy of the dilatator pupillae muscle. ... The fourth patient had a milder phenotype with regard to ocular features and renal disease, normal development, no neurologic abnormalities, and absence of muscle hypotonia, suggesting that she had residual protein function. ... Genotype/Phenotype Correlations Hasselbacher et al. (2006) stated that homozygosity or compound heterozygosity for LAMB2 mutations conferring complete loss of function (e.g., truncating mutations) appear to be associated consistently with the typical features of Pierson syndrome, including neonatal renal failure, severe ocular abnormalities, and neurologic impairment in long-term survivors, whereas patients with nontruncating (missense) LAMB2 mutations may display variable phenotypes ranging from a milder variant of Pierson syndrome to isolated congenital nephrotic syndrome.
    LAMB2, TNS2, COL4A3, LAMA2, NPHS1, NPHS2, RAPGEF5
    • Pierson Syndrome Orphanet
      A rare primary glomerular disease characterized by the association of congenital nephrotic syndrome, early onset renal failure and ocular anomalies with microcoria and severe neurodevelopment deficits. Epidemiology Less than 70 cases have been described in the literature to date. Clinical description Presentation is typically with congenital microcoria and heavy proteinuria. Proteinuria is usually nephrotic range, at or shortly after birth and progresses rapidly to early onset renal failure. The histological finding is usually diffuse mesangial sclerosis characterized by small and condensed appearance of glomerulus in which mesangial region shows some collagenous tissue.
    • Pierson Syndrome GARD
      Pierson syndrome is a very rare condition that mainly affects the kidneys and eyes. Signs and symptoms include congenital nephrotic syndrome and distinct ocular (eye) abnormalities, including microcoria (small pupils that are not responsive to light). Most affected children have early-onset, chronic renal failure ; neurodevelopmental problems ; and blindness. Hypotonia (poor muscle tone) and movement disorders have also been reported. Pierson syndrome is caused by changes (mutations) in the LAMB2 gene and is inherited in an autosomal recessive manner.
  • Epilepsy, Familial Temporal Lobe, 2 OMIM
    For a discussion of genetic heterogeneity of temporal lobe epilepsy, see ETL1 (600512). Clinical Features Berkovic et al. (1996) reported 38 individuals from 13 unrelated families with familial temporal lobe epilepsy. ... The disease phenotype was characterized by temporal lobe epilepsy, no deja vu or auditory or visual hallucinations, a high incidence of febrile seizures, mean age at onset of afebrile seizures of 8 years, low incidence of epileptic features on electroencephalography, no hippocampal sclerosis, and a usually good prognosis. ... Seizures were generalized tonic-clonic, although 2 patients had febrile seizures with focal features. Gurnett et al. (2007) emphasized that none of the individuals manifested clear evidence of temporal lobe epilepsy. Biochemical Features In hippocampal tissue from 10 patients with intractable temporal lobe epilepsy, Henshall et al. (2004) found increased DAP kinase (600831) expression and phosphorylation compared to controls.
    LGI1, DEPDC5
    • Epilepsy, Familial Temporal Lobe, 4 OMIM
      For a general phenotypic description and a discussion of genetic heterogeneity of familial temporal lobe epilepsy, see 600512. Clinical Features Deprez et al. (2007) reported a 5-generation Belgian family with dominantly inherited occipitotemporal lobe epilepsy and migraine with visual aura.
    • Familial Temporal Lobe Epilepsy Orphanet
      A rare, genetic epilepsy characterized by mostly benign simple or complex partial seizures with autonomic or psychic auras. Seizures occur infrequently, are of short duration and are usually well controlled with medication. Development and cognition are normal.
  • Cleft Palate With Or Without Ankyloglossia, X-Linked OMIM
    A number sign (#) is used with this entry because X-linked cleft palate with or without ankyloglossia (CPX) is caused by mutation in the TBX22 gene (300307) on chromosome Xq21. Clinical Features In a British Columbia Indian family, Lowry (1970) found 12 males with incomplete cleft of the secondary palate. ... Palatopharyngeal incompetence was a leading feature. The pedigree pattern suggested X-linked recessive inheritance. ... Cleft palate was the sole presenting feature in 6% of female carriers. Not all female carriers escaped a cleft, which affected 16% regardless of tongue phenotype. ... Sponenberg and Bowling (1985) described a similar disorder in Australian shepherd dogs; the features were cleft palate, syndactyly, polydactyly, tibiofibular shortening, brachygnathism, and often scoliosis.
    TBX22, CPOX, EBP, IRF6, PGK1, NECTIN1, SUMO1, CPXCR1, KLHL4
    • X-Linked Cleft Palate And Ankyloglossia Orphanet
      X-linked cleft palate and ankyloglossia is a rare, genetic developmental defect during embryogenesis syndrome characterized by the association of complete, partial or submucous cleft palate and ankyloglossia. Patients may also present abnormal uvula (e.g. absent, bifid, shortened or laterally deviated), short lingual frenulum and dental anomalies (e.g. buccal crossbite, absent and/or misshapen teeth). Digital abnormalities, such as mild clinodactyly and/or syndactyly, have also been reported.
  • Vitamin D Hydroxylation-Deficient Rickets, Type 1a OMIM
    Disorders of vitamin D metabolism or action lead to defective bone mineralization and clinical features including intestinal malabsorption of calcium, hypocalcemia, secondary hyperparathyroidism, increased renal clearance of phosphorus, and hypophosphatemia. ... Other Forms of Hypophosphatemic Rickets For a discussion of other forms of hypophosphatemic rickets, see ADHR (193100). Clinical Features Kitanaka et al. (1998) reported 4 unrelated Japanese patients with vitamin D-dependent rickets confirmed by genetic analysis. ... INHERITANCE - Autosomal recessive GROWTH Other - Failure to thrive - Poor growth - Growth retardation HEAD & NECK Head - Frontal bossing Teeth - Delayed tooth eruption - Enamel hypoplasia CHEST Ribs Sternum Clavicles & Scapulae - Enlargement of the costochondral junction - 'Bulging' of the costochondral junction - Deformed rib cage ABDOMEN External Features - Protuberant abdomen due to muscle weakness SKELETAL - Rickets - Increased fractures - Bone pain - Sparse bone trabeculae - Thin bony cortex Skull - Widened cranial sutures - Posterior flattening of the skull Limbs - Delayed opacification of the epiphyses - Widened, distorted epiphyses - 'Bulging' epiphyses - Frayed, irregular metaphyses - Curvatures of the femur, tibia, fibula - Lower limb deformities - Bowing of the legs - Enlargement of the wrists - Enlargement of the ankles - Subperiosteal erosions due to secondary hyperparathyroidism MUSCLE, SOFT TISSUES - Hypotonia - Muscle weakness - Difficulty walking - Difficulty standing NEUROLOGIC Central Nervous System - Delayed motor development - Seizures due to hypocalcemia Behavioral Psychiatric Manifestations - Irritability ENDOCRINE FEATURES - Secondary hyperparathyroidism LABORATORY ABNORMALITIES - Hypocalcemia - Hypophosphatemia - Increased serum parathyroid hormone (PTH) - Increased serum alkaline phosphatase - Generalized aminoaciduria - Markedly decreased or absent serum 1,25-dihydroxyvitamin D3 - Normal serum 25-hydroxyvitamin D3 MISCELLANEOUS - Clinical onset within first 2 years of life - Can be treated with physiologic levels of 1,25-dihydroxyvitamin D3 or 1-alpha-hydroxyvitamin D3 - Increased frequency among French-Canadians from the Charlevoix-Saguenay-Lac Saint Jean area of Quebec (carrier rate 1 in 26) MOLECULAR BASIS - Caused by mutations in the 25-hydroxyvitamin D3-1-alpha-hydroxylase gene (CYP27B1, 609506.0001 ). ▲ Close
    CYP27B1, CYP2R1, PTH, CYP2B6, CYP27A1, FDX1
    • Hypocalcemic Vitamin D-Dependent Rickets Orphanet
      Hypocalcemic vitamin D-dependent rickets (VDDR-I) is an early-onset hereditary vitamin D metabolism disorder characterized by severe hypocalcemia leading to osteomalacia and rachitic bone deformations, and moderate hypophosphatemia. Epidemiology The prevalence at birth is estimated at around 1/2,000. The disease is more frequent in the French Canadian population in the Saguenay region of Quebec. Clinical description The disease manifests within the first year of life with hypotonia, tetany, seizures, muscle weakness, and poor growth. Progressively, patients present with rachitic deformities (bowed legs, rachitic rosary...). Enamel hypoplasia is occasionally observed. Etiology The disease is due to inactivating mutations in the CYP27B1 gene (12q14) that codes for 1-alpha-hydroxylase which converts the vitamin D precursor calcidiol to calcitriol, the vitamin D active metabolite.
    • Vitamin D-Dependent Rickets MedlinePlus
      The lack of calcium and phosphate slows bone mineralization, which leads to soft, weak bones and other features of vitamin D-dependent rickets.
    • Vitamin D Hydroxylation-Deficient Rickets, Type 1b OMIM
      For a general phenotypic description and discussion of genetic heterogeneity of rickets due to disorders in vitamin D metabolism or action, see vitamin D-dependent rickets type 1A (VDDR1A; 264700). Clinical Features Casella et al. (1994) described 2 brothers of Nigerian descent who had rickets at a young age despite a history of adequate vitamin D intake.
  • Metaphyseal Chondrodysplasia, Schmid Type OMIM
    Description Schmid-type metaphyseal chondrodysplasia is characterized by short stature and bowing of the long bones; radiographic features include widening and irregularity of the growth plates, especially in the distal and proximal femora (summary by Makitie et al., 2005). Clinical Features Stephens (1943) reported a Mormon kindred in which over 40 members of 4 generations were affected with what he considered to be achondroplasia. ... They suggested that the condition was often overdiagnosed. Significant radiologic features included an enlarged capital femoral epiphysis in early childhood, coxa vara, greater involvement of the distal femoral metaphysis than the proximal, anterior rib changes, and a normal spine. ... Elliott et al. (2005) concluded that mild hand involvement that appears to resolve with age is a common feature of MCDS and should not exclude the diagnosis in young patients.
    COL10A1, NT5DC1, MMP13, ABCC1, MUC1, RMRP, MANF, MLYCD, MARCKSL1, WLS, RPPH1, RNASEH1
    • Metaphyseal Chondrodysplasia Schmid Type Wikipedia
      Schmid metaphyseal chondrodysplasia Other names MCDS [1] This condition is inherited in ab autosomal dominant manner Specialty Orthopedic Metaphyseal chondrodysplasia Schmid type is a type of chondrodysplasia associated with a deficiency of collagen, type X, alpha 1 . [2] [3] [4] Unlike other " rickets syndromes", affected individuals have normal serum calcium, phosphorus, and urinary amino acid levels. Long bones are short and curved, with widened growth plates and metaphyses . [5] It is named for the German researcher F. Schmid, who characterized it in 1949. [6] References [ edit ] ^ "Metaphyseal chondrodysplasia Schmid type | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program" . rarediseases.info.nih.gov . Retrieved 20 October 2019 . ^ Mäkitie O, Susic M, Ward L, Barclay C, Glorieux FH, Cole WG (September 2005). "Schmid type of metaphyseal chondrodysplasia and COL10A1 mutations--findings in 10 patients".
    • Metaphyseal Chondrodysplasia, Schmid Type Orphanet
      Other metaphyseal dysplasias (such as cartilage-hair hypoplasia or Jansen type metaphyseal chondrodysplasia; see these terms) can be excluded as they are associated with very short stature and other features. Antenatal diagnosis Prenatal diagnosis should not be proposed for this disease.
    • Metaphyseal Chondrodysplasia Schmid Type GARD
      Metaphyseal chondrodysplasia, Schmid type (MCDS) is a type of skeletal disorder in which there is abnormal bone formation at the end of the long bones (metaphyses). Symptoms include short stature with abnormally short arms and legs (short-limbed dwarfism) and bowed legs (genu varum). Additional signs and symptoms may include lumbar lordosis , leg pain, joint pain, hip deformities, and an outward flaring of the bones of the lower rib cage. As a result of the hip and leg findings, individuals with this condition may have an unusual walk that resembles a waddle. The condition is often mistaken for vitamin D-deficient rickets . MCDS is caused by a mutation in one of the collagen genes known as COL10A1 .
  • Ichthyosis Vulgaris OMIM
    Patients with homozygous or compound heterozygous mutations in this gene have a more severe phenotype. Clinical Features Ichthyosis is one of the most frequent single-gene disorders in humans. ... The disorder in the mother was clinically and histologically of the dominant type, whereas the affected sons showed features of both the autosomal dominant and X-linked recessive forms. The authors concluded that the mother was heterozygous for both forms. Biochemical Features Anton-Lamprecht (1978) pointed out that electron microscopy is particularly revealing in dominant disorders in which structural abnormality of a protein is likely to be found, whereas biochemistry is more likely to be revealing in recessive disorders. ... The association of ichthyosis vulgaris with atopic diathesis is well established; 37 to 50% of people with ichthyosis vulgaris have atopic diseases, and roughly 8% of patients with atopic dermatitis (603165) have classic features of ichthyosis vulgaris. Nomura et al. (2007) sequenced the entire FLG gene in 7 Japanese patients with ichthyosis vulgaris from 4 unrelated families who were negative for the R501X and 2282del4 mutations, and identified heterozygosity for 2 novel mutations, S2554X (135940.0003) and 3321delA (135940.0004), respectively.
    FLG, LBR, FLG-AS1, STS, COL7A1, JUN, KRT10, TGM1, TGM3, TGM5
    • Ichthyosis Vulgaris Wikipedia
      Ichthyosis vulgaris Ichthyosis vulgaris #1 (top-left) Specialty Medical genetics Ichthyosis vulgaris (also known as "Autosomal dominant ichthyosis," [1] and "Ichthyosis simplex" [1] ) is a skin disorder causing dry, scaly skin. It is the most common form of ichthyosis , [2] : 486 affecting around 1 in 250 people. [3] For this reason it is known as common ichthyosis . It is usually an autosomal dominant inherited disease (often associated with filaggrin ), although a rare non-heritable version called acquired ichthyosis exists. [4] : 560 Contents 1 Presentation 1.1 Associated conditions 2 Genetics 3 Diagnosis 4 See also 5 References 6 External links Presentation [ edit ] The symptoms of the inherited form of ichthyosis vulgaris are not usually present at birth but generally develop between 3 months and 5 years of age. [5] [6] The symptoms will often improve with age, although they may grow more severe again in old age. [7] The condition is not life-threatening; the impact on the patient, if it is a mild case, is generally restricted to mild itching and the social impact of having skin with an unusual appearance. People with mild cases have symptoms that include scaly patches on the shins, fine white scales on the forearms and upper arms, and rough palms. People with the mildest cases have no symptoms other than faint, tell-tale "mosaic lines" between the Achilles tendons and the calf muscles.
    • Ichthyosis Vulgaris GARD
      Ichthyosis vulgaris is a common skin disorder passed down through families that leads to dry, scaly skin. It often begins in early childhood. Treatment may include heavy duty moisturizers which contain chemicals that help the skin to shed normally, including lactic acid , salicylic acid, and urea. Ichthyosis vulgaris can be a nuisance, but it rarely affects overall health. The condition usually disappears during adulthood, but may return in later years. This condition is inherited in an autosomal dominant pattern.
  • Caffey Disease OMIM
    A number sign (#) is used with this entry because of evidence that Caffey disease is caused by heterozygous mutation in the alpha-1 collagen type I gene (COL1A1; 120150) on chromosome 17q21. Clinical Features Infantile cortical hyperostosis has somewhat unusual features for a hereditary disorder. ... Postmortem radiographs, autopsy, and histologic study showed typical features of a severe form of prenatal cortical hyperostosis. ... None of the affected individuals or obligate carriers in any of the families had clinical signs of the major type I collagen disorder, osteogenesis imperfecta (see 166200); however, in 2 of the 3 families, individuals carrying the mutation did have joint hyperlaxity, hyperextensible skin, and inguinal hernias, features seen in Ehlers-Danlos syndrome (see 130000), some forms of which are caused by mutations in COL1A1.
    COL1A1, A4GALT, AHSG, COL1A2, SLC37A2
    • Caffey Disease GARD
      Caffey disease is a bone disorder that most often occurs in babies. It is characterized by the excessive formation of new bone (hyperostosis) in the jaw, shoulder blades, collarbones, and shafts of long bones in the arms and legs. Affected bones may double or triple in width. In some cases, two bones that are next to each other may become fused. Caffey disease is caused by a mutation in the COL1A1 gene. It is inherited in an autosomal dominant pattern, but not all people who inherit the mutation develop signs and symptoms. This is due to incomplete penetrance .
    • Caffey Disease MedlinePlus
      Caffey disease, also called infantile cortical hyperostosis, is a bone disorder that most often occurs in babies. Excessive new bone formation (hyperostosis) is characteristic of Caffey disease. The bone abnormalities mainly affect the jawbone, shoulder blades (scapulae), collarbones (clavicles), and the shafts (diaphyses) of long bones in the arms and legs. Affected bones may double or triple in width, which can be seen by x-ray imaging. In some cases two bones that are next to each other, such as two ribs or the pairs of long bones in the forearms (radius and ulna) or lower legs (tibia and fibula) become fused together.
    • Caffey Disease Orphanet
      Diagnostic methods Diagnosis is based on clinical features and radiologic findings of subperiosteal cortical hyperostosis of the diaphyses of the long bones (with sparing of the epiphyses), ribs, scapulae, clavicles, and mandible in a child age 2 months to 5 years.
    • Caffey Disease GeneReviews
      Option 2 When the diagnosis of Caffey disease is not considered because an individual has atypical phenotypic features, comprehensive genomic testing (which does not require the clinician to determine which gene[s] are likely involved) is the best option. ... Often the clinical history and presence of fractures, which are not usually a presenting feature of Caffey disease, aid in distinguishing the two conditions [Al Kaissi et al 2009, Lo et al 2010].
  • Tumor Predisposition Syndrome OMIM
    ., 2011, and Popova et al., 2013). Clinical Features Wiesner et al. (2011) reported 2 unrelated families with autosomal dominant inheritance of a skin tumor predisposition syndrome. ... Some of the neoplasms showed atypical features such as high cellularity or nuclear pleomorphism, and were classified as 'neoplasms of uncertain malignant potential;' these individuals were managed as if they had melanoma. ... None of the affected individuals had intellectual disabilities or dysmorphic features, or lung or breast cancer. Testa et al. (2011) reported 2 unrelated families with multiple cases of malignant mesothelioma apparently transmitted in an autosomal dominant pattern. ... INHERITANCE - Autosomal dominant HEAD & NECK Eyes - Uveal melanoma RESPIRATORY Lung - Mesothelioma, malignant, after asbestos exposure - Lung adenocarcinoma SKIN, NAILS, & HAIR Skin - Melanocytic skin tumors/papules, skin-colored to reddish-brown, dome-shaped or pedunculated, well circumscribed with an average size of 5 mm (in 2 families) - Cutaneous melanoma Skin Histology - Dermal tumors composed of epithelioid melanocytes - Abundant cytoplasm - Prominent nucleoli - Melanocytes contain large vesicular nuclei with varying shapes - Some show atypical features, such as nuclear pleomorphism NEUROLOGIC Central Nervous System - Meningioma NEOPLASIA - Mesothelioma, malignant, after asbestos exposure - Uveal melanoma - Cutaneous melanoma - Meningioma - Renal cell carcinoma, usually clear cell type MISCELLANEOUS - Tumor predisposition syndrome MOLECULAR BASIS - Caused by mutation in the BRCA1-associated protein 1 (BAP1, 603089.0001 ) ▲ Close
    BAP1, BRCA2, MRE11, PMS2, PALB2, FH, DICER1, BRAF, ETV5, NF1, NF2, TP53, TSC1, VHL, POT1, KIAA1549
    • Bap1 Tumor Predisposition Syndrome MedlinePlus
      BAP1 tumor predisposition syndrome is an inherited disorder that increases the risk of a variety of cancerous (malignant) and noncancerous (benign) tumors, most commonly certain types of tumors that occur in the skin, eyes, kidneys, and the tissue that lines the chest, abdomen, and the outer surface of the internal organs (the mesothelium). Affected individuals can develop one or more types of tumor, and affected members of the same family can have different types. Some people with BAP1 tumor predisposition syndrome develop growths in the skin known as atypical Spitz tumors. People with this syndrome may have more than one of these tumors, and they can have dozens. Atypical Spitz tumors are generally considered benign, although it is unclear if they can become cancerous.
    • Bap1-Related Tumor Predisposition Syndrome Orphanet
      BAP1-related tumor predisposition syndrome (TPDS) is an inherited cancer-predisposing syndrome, associated with germline mutations in BAP1 tumor suppressor gene. The most commonly observed cancer types include uveal melanoma, malignant mesothelioma, renal cell carcinoma, lung, ovarian, pancreatic, breast cancer and meningioma, with variable age of onset. Common cutaneous manifestations include malignant melanoma, basal cell carcinoma and benign melanocytic BAP1-mutated atypical intradermal tumors (MBAIT) presenting as multiple skin-coloured to reddish-brown dome-shaped to pedunculated, well-circumscribed papules with an average size of 5 mm, histologically predominantly composed of epithelioid melanocytes with abundant amphophilic cytoplasm, prominent nucleoli and large, vesicular nuclei that vary substantially in size and shape.
  • Immunodeficiency 27a OMIM
    Patients with partial AR IFNGR1 deficiency are susceptible to BCG and environmental mycobacteria, but they have a milder clinical disease and better prognosis than patients with complete AR IFNGR1 deficiency. The clinical features of children with complete AR IFNGR1 deficiency are usually more severe than those in individuals with AD IFNGR1 deficiency (IMD27B), and mycobacterial infection often occurs earlier (mean age of 1.3 years vs 13.4 years), with patients having shorter mean disease-free survival. Salmonellosis is present in about 5% of patients with AR or AD IFNGR1 deficiency, and other infections have been reported in single patients (review by Al-Muhsen and Casanova, 2008). Clinical Features Families with multiple cases of disseminated atypical mycobacteriosis, a rare disorder, were reported by Engbaek (1964) and Uchiyama et al. (1981). ... Genotype/Phenotype Correlations Dorman et al. (2004) compared the clinical features of recessive and dominant IFNGR1 deficiencies using a worldwide cohort of patients. ... Dorman et al. (2004) concluded that there is a strong correlation between the IFNGR1 genotype, clinical disease features, and the cellular responsiveness to IFNG.
    IFNGR1
    • Mendelian Susceptibility To Mycobacterial Diseases Due To Complete Ifngammar1 Deficiency Orphanet
      Mendelian susceptibility to mycobacterial diseases (MSMD) due to complete interferon gamma receptor 1 (IFN-gammaR1) deficiency is a genetic variant of MSMD (see this term) characterized by a complete deficiency in IFN-gammaR1, leading to impaired IFN-gamma immunity and, consequently, to severe and often fatal infections with bacillus Calmette-Guérin (BCG) and other environmental mycobacteria (EM). Epidemiology The prevalence is unknown. Clinical description Severe and often fatal BCG and EM infections begin in early childhood (before the age of 3) as a complete deficiency displays complete clinical penetrance in childhood. The most common pathogens include Mycobacterium fortuitum , Mycobacterium chelonae , Mycobacterium smegmatis and Mycobacterium peregrinum . Infection is disseminated and can involve soft tissue, bone marrow, lungs, skin, bones and lymph nodes. Manifestations include fever, weight loss, hepatosplenomegaly, lymphadenopathies and lepromatous-like lesions.
    • Autosomal Recessive Mendelian Susceptibility To Mycobacterial Diseases Due To Partial Ifngammar1 Deficiency Orphanet
      A genetic variant of mendelian susceptibility to mycobacterial diseases (MSMD) characterized by a partial deficiency in IFN-gammaR1, leading to a residual response to IFN-gamma and, consequently, to recurrent, moderately severe infections with bacillus Calmette-Guérin (BCG) and other environmental mycobacteria (EM). Epidemiology The prevalence is unknown. The same homozygous mutations have been reported in 14 patients in 11 kindreds from Poland, Portugal, Spain and Chile, thus reflecting a founder effect. Clinical description Patients present with moderately severe mycobacterial infections, BCG or EM diseases. These infections are recurrent but less severe than those seen in MSMD due to complete IFN-gammaR1 and IFN-gammaR2 deficiencies (see these terms). Infections with Mycobacterium tuberculosis have also been reported in patients with this disorder.
  • Myopathy, Myofibrillar, 3 OMIM
    Spheroid body myopathy (182920) is an allelic disorder with overlapping features. Description Myofibrillar myopathy refers to a genetically heterogeneous group of muscular disorders characterized by a pathologic morphologic pattern of myofibrillar degradation and abnormal accumulation of proteins involved with the sarcomeric Z disc (summary by Foroud et al., 2005). ... Straub et al. (2018), on behalf of the LGMD workshop study group, reclassified LGMD1A as a form of myofibrillar myopathy. Clinical Features Gilchrist et al. (1988) reported a large family from southeastern West Virginia diagnosed with autosomal dominant limb-girdle muscular dystrophy. ... One patient had a brother with distal leg weakness and another patient had an affected brother and an affected son, suggesting autosomal dominant inheritance. The main features included progressive distal muscle weakness and peripheral neuropathy with hyporeflexia. ... INHERITANCE - Autosomal dominant CARDIOVASCULAR Heart - Cardiomyopathy SKELETAL Feet - Achilles tendon contractures MUSCLE, SOFT TISSUES - Muscle weakness, distal, progressive - Muscle atrophy, distal - Proximal muscle involvement may occur - Muscle stiffness or aching - EMG shows myopathic and neurogenic changes - Muscle biopsy shows myofibrillar myopathy - Abnormal muscle fibers with amorphous, granular, or hyaline deposits - Congophilic staining - Increased staining for myotilin, dystrophin, desmin - Electron microscopy shows dense material emanating from the Z-disk - Phagocytic vacuoles with degraded membranous material NEUROLOGIC Peripheral Nervous System - Peripheral neuropathy - Hyporeflexia/areflexia in lower limbs LABORATORY ABNORMALITIES - Increased serum creatine kinase MISCELLANEOUS - Adult onset (mean 60 years) - Slowly progressive disorder - Limb-girdle muscular dystrophy 1A (LGMD1A, 159000 ) is an allelic disorder with overlapping clinical features MOLECULAR BASIS - Caused by mutations in the titin immunoglobulin domain protein gene (TTID, 604103.0002 ). ▲ Close
    • Autosomal Dominant Limb-Girdle Muscular Dystrophy Type 1a Orphanet
      A rare subtype of autosomal dominant limb girdle muscular dystrophy characterized by an adult onset of proximal shoulder and hip girdle weakness (that later progresses to include distal weakness), nasal speech and dysarthria. Other frequent findings include tightened heel cords, reduced deep-tendon reflexes and elevated creatine kinase serum levels. Respiratory failure, as well as mild facial weakness and dysphagia, may also be observed.
  • Mitochondrial Complex Iii Deficiency, Nuclear Type 2 OMIM
    For a discussion of genetic heterogeneity of mitochondrial complex III deficiency, see MC3DN1 (124000). Clinical Features Ghezzi et al. (2011) reported 4 Italian patients with mitochondrial complex III deficiency. ... A fourth patient from southern Italy had normal psychomotor development until age 42 years, when he developed subacute, rapidly progressive neurologic failure resulting in death at age 45. Features included weakness with fasciculations, apraxia, dysarthria, bradykinesia, dystonia, paraparesis, and behavioral changes. ... Nogueira et al. (2013) reported 4 Portuguese sibs, born of parents who were likely related, with a complex neurodegenerative disease associated with significant psychiatric features. The age at onset varied between 12 and 34 years, but followed a relentlessly progressive course in each patient, resulting in death in 2 patients between ages 30 and 49 years. ... Some patients had extrapyramidal signs. The psychiatric features progressed to include major depression, psychosis, and extremely poor social interactions.
    TTC19
  • Tibial Muscular Dystrophy, Tardive OMIM
    Homozygous mutation in the titin gene causes the more severe limb-girdle muscular dystrophy type 2J (LGMD2J; 608807). Clinical Features Markesbery et al. (1974) reported a late adult-onset, autosomal dominant form of distal myopathy with onset in the anterior compartment of the legs rather than in the hands, which is the presenting feature of Welander myopathy (604454). ... Heterogeneity Genetic Heterogeneity Felice et al. (1999) reported a family with autosomal dominant distal myopathy spanning 4 generations in whom linkage to Nonaka distal myopathy (605820) on 9p, MPD1 (160500) on 14q, Miyoshi myopathy on 2p13, and TMD on 2q31 was excluded. Clinical features included onset in the second to third decade of foot drop, difficulty in stair climbing, and progressive leg weakness. ... INHERITANCE - Autosomal dominant MUSCLE, SOFT TISSUES - Weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle) - Atrophy of the muscles in the anterior compartment of the lower leg - 'Steppage' gait - Reduced ankle dorsiflexion - Replacement of affected muscle tissue with fatty tissue - Biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size - Myopathy seen on EMG MISCELLANEOUS - Adult onset (after age 35 years) - Slow progression without marked disability - Incomplete penetrance - Cardiomyopathy is not a feature MOLECULAR BASIS - Caused by heterozygous mutation in the titin gene (TTN, 188840.0004 ) ▲ Close
    TTN, MYH7, TTN-AS1, CAPN3, GTF2H1, CXCL8, ITGAL, COMT, NFKB1, CCL2, COL4A3, VCP, SQSTM1, KHDRBS1, NUP62, DCTN4, MAP1LC3B, CMYA5
    • Tibial Muscular Dystrophy MedlinePlus
      Tibial muscular dystrophy is a condition that affects the muscles at the front of the lower leg. The signs and symptoms of this condition typically appear after age 35. The first sign is usually weakness and wasting (atrophy) of a muscle in the lower leg called the tibialis anterior. This muscle helps control up-and-down movement of the foot. Weakness in the tibialis anterior muscle makes it difficult or impossible to walk on the heels, but it usually does not interfere significantly with regular walking. Muscle weakness worsens very slowly in people with tibial muscular dystrophy.
  • Autoimmune Lymphoproliferative Syndrome, Type Iii OMIM
    For a general description and a discussion of genetic heterogeneity of ALPS, see 601859. Clinical Features Salzer et al. (2013) reported a 12-year-old boy, born of consanguineous Turkish parents, with a primary immune deficiency syndrome characterized by B-cell deficiency and severe autoimmunity. ... By age 3 years, he had hepatosplenomegaly and generalized lymphadenopathy associated with low-grade herpes viremia. Additional autoimmune features included polychondritis and antiphospholipid syndrome, with antinuclear, anti-dsDNA, and anticardiolipin IgG antibodies. ... The patient's sister and brother presented at ages 10 and 6 years, respectively, with features of SLE, including rash, arthritis, and glomerulonephritis, but without a frank lymphoproliferative disorder. ... In a follow-up of the patients reported by Andre et al. (2007), Belot et al. (2013) noted that none of them presented with features of early-onset immunodeficiency, although 1 died at age 13 years of septic shock.
    FAS, FASLG, CASP10, NRAS, CASP8, PRKCD, TNFAIP3, RASGRP1, IL10, TRBV20OR9-2, KRAS, SPP1, UNC13D, IL17A, STAT3, FOXP3, B3GAT1, CTLA4, PRF1, CDR3, FADD, TIMP1, TNF, MIR21, EOMES, MIR146A, IL17F, PPIG, LSM2, BCL2L11, TNFRSF13C, KLRG1, TCF7, MMRN1, SMUG1, ADA2, KRT20, LYPLA1, ABCD1, HNF1A, TAP1, AIRE, XIAP, BCL2, CASP9, MS4A1, CD27, CD28, CD48, LRBA, CETN2, COL4A2, MTOR, HLA-A, HMMR, IFNG, IL2RA, ISG20, SH2D1A, PCNA, PIK3CD, APCS, SLC6A3, STAT5B, RN7SL263P
    • Autoimmune Lymphoproliferative Syndrome Wikipedia
      "Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome" .
    • Autoimmune Lymphoproliferative Syndrome GeneReviews
      Two publications have provided significant new insights into the features, complications, natural history, and prognosis of ALPS. ... Biochemical markers are consistent with ALPS, but the affected individuals described to date do not have the characteristic clinical features of ALPS, including lymphadenopathy and splenomegaly [Bolze et al 2010, Oliveira 2013, Savic et al 2015]. ... Several non-X-linked forms of hyper IgM syndrome have now been identified. In varying degrees, they share features with the X-linked form (see X-Linked Hyper IgM Syndrome), caused by pathogenic variants in CD40LG . Shared features include recurrent bacterial infections such as otitis media, sinusitis, and pneumonias. ... STAT3 gain-of-function variants causing autoimmune disease can result in clinical features such as lymphadenopathy, elevated α/β-DNT cells, and autoimmune cytopenia, resembling ALPS.
    • Autoimmune Lymphoproliferative Syndrome OMIM
      ALPS5 (616100) is caused by mutation in the CTLA4 gene (123890). Clinical Features Canale and Smith (1967) described a childhood syndrome of lymphadenopathy and splenomegaly associated with autoimmune hemolytic anemia and thrombocytopenia. ... These relatives also showed in vitro abnormalities of FAS-mediated lymphocyte apoptosis, but clinical features of ALPS were not present. In 1 ALPS patient, no FAS or FASL gene mutations were identified, and Sneller et al. (1997) proposed the designation ALPS type II to refer to the syndrome in the absence of mutations in these genes. ... All 10 patients with FAS mutations had defective lymphocyte apoptosis and most had other features of ALPS. The average age of ALPS onset was 5 years, whereas the average age of lymphoma diagnosis was 28 years. ... Magerus-Chatinet et al. (2011) reported 7 unrelated patients with typical features of ALPS associated with heterozygous germline mutations in the FAS gene. ... Lenardo (1999) noted that although this patient satisfied the rheumatologic criteria for a diagnosis of SLE, the features were more consistent with ALPS.
    • Autoimmune Lymphoproliferative Syndrome GARD
      Autoimmune lymphoproliferative syndrome (ALPS) is a disorder in which the body cannot properly regulate the number of immune system cells (lymphocytes). This results in the overproduction of lymphocytes, which build up and cause enlargement of the lymph nodes, liver and spleen. Affected individuals have an increased risk of developing cancer of the immune system cells (lymphoma) and may be at increased risk for other cancers. They can also have a variety of autoimmune disorders , most of which damage the blood cells. Some of the autoimmune disorders associated with ALPS can also damage the kidneys, liver, eyes, nerves, or connective tissues.
    • Autoimmune Lymphoproliferative Syndrome MedlinePlus
      Autoimmune lymphoproliferative syndrome (ALPS) is an inherited disorder in which the body cannot properly regulate the number of immune system cells (lymphocytes). ALPS is characterized by the production of an abnormally large number of lymphocytes (lymphoproliferation). Accumulation of excess lymphocytes results in enlargement of the lymph nodes (lymphadenopathy), the liver (hepatomegaly), and the spleen (splenomegaly). Autoimmune disorders are also common in ALPS. Autoimmune disorders occur when the immune system malfunctions and attacks the body's own tissues and organs. Most of the autoimmune disorders associated with ALPS target and damage blood cells .
    • Autoimmune Lymphoproliferative Syndrome Orphanet
      A rare, inherited disorder characterized by non-malignant lymphoproliferation, multilineage cytopenias, and a lifelong increased risk of Hodgkin's and non-Hodgkin's lymphoma. Epidemiology The prevalence of ALPS is unknown. It has been characterized in more than 500 patients to date and has been reported worldwide in various ethnic groups. Clinical description ALPS is clinically heterogeneous with the following primary clinical signs: lymphoproliferation, manifesting as lymphadenopathy and hepatosplenomegaly with or without hypersplenism, often improving with age, autoimmune disease, mostly involving blood cells, and an increased risk of lymphoma lifelong. Many patients develop non-malignant lymphoproliferation during the first years of life. Clinical manifestations of autoimmunity in the form of hemolytic anemia, thrombocytopenia, neutropenia, or autoimmune hepatitis are of variable severity but these signs are often absent at the time of diagnosis.
    • Autoimmune Lymphoproliferative Syndrome, Type Iia OMIM
      For a phenotypic description and a discussion of genetic heterogeneity of ALPS, see 601859. Clinical Features Wang et al. (1999) reported 2 unrelated patients with ALPS2A.
  • Grin2a-Related Speech Disorders And Epilepsy GeneReviews
    Single-gene testing (sequence analysis of GRIN2A, followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found may be considered first in individuals with features that are highly suggestive of GRIN2A -related speech disorder and epilepsy. However, because many of these features overlap with those of other genetic epileptic encephalopathies, multigene panels or comprehensive genomic testing are often performed in lieu of single-gene testing. ... Development ranges from normal to severely impaired. Mild dysmorphic features may be present in individuals with a contiguous gene deletion. ... Reutlinger et al [2010] described three individuals with 16p13 deletions involving multiple genes and complete or partial heterozygous deletion of GRIN2A . All had mild dysmorphic features, intellectual disability, and epilepsy involving the rolandic region. ... Pathogenic variants in RBFOX1 and RBFOX3 may play a contributory role in some cases [Lal et al 2013, Turner et al 2015b]. At present, no clinical features differentiate GRIN2A -related EAS from EAS of other genetic causes.
  • Retinal Vasculopathy With Cerebral Leukoencephalopathy And Systemic Manifestations GeneReviews
    Brain MRI abnormalities are restricted to the white matter (see Clinical Characteristics, Neurologic Features). Family history of middle-age onset of disease manifestations consistent with an autosomal dominant inheritance pattern Note: Absence of a known family history of similarly affected individuals does not preclude the diagnosis. ... The proportion of individuals with suggestive features of RVCL-S who do not have an identifiable heterozygous pathogenic variant in TREX1 has not been systematically studied. 5. ... Clinical course of RVCL-S Adapted from Pelzer et al [2019] Ophthalmologic Features Symptoms Symptoms caused by retinal vasculopathy are the most common presenting finding in individuals with RVCL-S but can also develop later in the disease course. ... Macular edema and neovascular glaucoma may develop as a complication of vascular retinopathy. Neurologic Features Symptoms Focal neurologic symptoms were reported in 40/72 individuals. ... Penetrance Penetrance of RVCL-S is age dependent; however, it is thought that all individuals with a heterozygous pathogenic TREX1 variant will develop features of this condition if they live long enough.
    TREX1, ATRIP
    • Vasculopathy, Retinal, With Cerebral Leukodystrophy OMIM
      A subset of affected individuals have systemic vascular involvement evidenced by Raynaud's phenomenon, micronodular cirrhosis, and glomerular dysfunction (summary by Richards et al., 2007). Clinical Features Grand et al. (1988) reported a family in which multiple individuals had a disorder characterized by central nervous system degeneration and retinal vasculopathy. ... Vascular retinopathy is also a prominent feature of the hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS) described by Grand et al. (1988), Gutmann et al. (1989), and Jen et al. (1997). The distinctive feature in the families reported by Grand et al. (1988) and Jen et al. (1997) was the presence of progressive subcortical contrast-enhancing lesions with surrounding edema, mimicking tumors and prompting biopsy in numerous affected family members.
    • Autosomal Dominant Retinal Vasculopathy With Cerebral Leukodystrophy Wikipedia
      This article has multiple issues. Please help improve it or discuss these issues on the talk page . ( Learn how and when to remove these template messages ) This article needs additional citations for verification . Please help improve this article by adding citations to reliable sources . Unsourced material may be challenged and removed. Find sources: "Autosomal dominant retinal vasculopathy with cerebral leukodystrophy" – news · newspapers · books · scholar · JSTOR ( June 2016 ) ( Learn how and when to remove this template message ) This article needs editing for compliance with Wikipedia's Manual of Style . Please help improve it if you can. ( August 2015 ) ( Learn how and when to remove this template message ) This article's factual accuracy is disputed . Relevant discussion may be found on the talk page . Please help to ensure that disputed statements are reliably sourced . ( August 2015 ) ( Learn how and when to remove this template message ) ( Learn how and when to remove this template message ) Autosomal dominant retinal vasculopathy with cerebral leukodystrophy Other names Retinal vasculopathy and cerebral leukoencephalopathy Diagram depicts the mode of inheritance of this condition Autosomal Dominant Retinal Vasculopathy with Cerebral Leukodystrophy (AD-RVCL) (previously known also as Cerebroretinal Vasculopathy, CRV, or Hereditary Vascular Retinopathy, HVR or Hereditary Endotheliopathy, Retinopathy, Nephropathy, and Stroke, HERNS) is an inherited condition resulting from a frameshift mutation to the TREX1 gene.
    • Retinal Vasculopathy With Cerebral Leukoencephalopathy And Systemic Manifestations Orphanet
      Retinal vasculopathy and cerebral leukodystrophy (RVCL) is an inherited group of small vessel diseases comprised of cerebroretinal vasculopathy (CRV), hereditary vascular retinopathy (HRV) and hereditary endotheliopathy with retinopathy, nephropathy and stroke (HERNS; see these terms); all exhibiting progressive visual impairment as well as variable cerebral dysfunction.
    • Retinal Vasculopathy With Cerebral Leukodystrophy With Systemic Manifestations GARD
      Retinal vasculopathy with cerebral leukodystrophy and systemic manifestations (RVCL-S) affects the small blood vessels in the central nervous system and other organs. Symptoms begin in adulthood and can include loss of vision, Raynaud's disease , kidney and liver disease, and cognitive problems that get worse over time. Other symptoms may include migraines, gastrointestinal bleeding, and hypothyroidism . Death often occurs 10-15 years after the first symptoms appear. RVCL-S is caused by genetic variations in the TREX1 gene, and is inherited in an autosomal dominant pattern. Diagnosis is based on the symptoms, clinical exam, imaging studies of the brain, and may be confirmed by the results of genetic testing.
  • Conotruncal Heart Malformations OMIM
    Mutation in the ZFPM2 gene (603693) has been identified in patients with DORV. Clinical Features In a study of the families of children with cardiac malformations, Pierpont et al. (1988) found that conotruncal malformations carry a higher recurrence risk than other cardiac defects and proposed a monogenic mode of inheritance. ... Le Marec et al. (1989) had raised the question of autosomal recessive inheritance of truncus arteriosus. Typical facial features of conotruncal anomaly face syndrome (CAFS) are ocular hypertelorism (with increased interpupillary distance due to increased separation of the inner canthi), short palpebral fissures, 'bloated' eyelids, a low nasal bridge, a small mouth, and minor ear lobe anomalies. These features are almost always associated with nasal voice (often associated with cleft palate/submucosal cleft palate/bifid uvula) and mild mental retardation (frequently associated with developmental retardation and, occasionally, dwarfism), and often associated with cardiovascular anomalies. ... In a study of the origin of the deletion using microsatellite analyses in 48 de novo patients, the mother was shown to be the source in 65% of CAFS patients, while the father was the source in 64% of DGA patients. In addition to the major features of CAFS, other notable extracardiac anomalies were susceptibility to infection, schizophrenia, atrophy or dysmorphism of the brain, thrombocytopenia, short stature, facial palsy, anal atresia, and mild limb abnormalities. ... All patients with the deletion showed additional clinical features of the velocardiofacial syndrome.
    NKX2-6, TBX1, NKX2-5, GATA6, GDF1, ZFPM2, KCNJ4, SLC38A3, SLC22A10, LINC02570, DGCR, PTH, TYMS
    • Conotruncal Heart Malformations Orphanet
      A group of congenital cardiac outflow tract anomalies that include such defects as tetralogy of Fallot, pulmonary atresia with ventricular septal defect, double-outlet right ventricle (DORV), double-outlet left ventricle, truncus arteriosus and transposition of the great arteries (TGA), among others. This group of defects is frequently found in patients with 22q11.2 deletion syndrome . A deletion of chromosome 22q11.2 has equally been associated in a subset of patients with various types of isolated non-syndromic conotruncal heart malformations (with the exception of DORV and TGA where this is very uncommon).
  • Hydrocephalus Due To Congenital Stenosis Of Aqueduct Of Sylvius OMIM
    See HYC1 (236600) for a discussion of nonsyndromic autosomal recessive forms of hydrocephalus. Clinical Features The hydrocephalus may become arrested and the principal manifestations may be mental deficiency and spastic paraplegia. ... Schrander-Stumpel et al. (1995) reported 5 families with definite hydrocephalus accompanied by various features, including macrocephaly, mental retardation, spastic paraplegia, adducted thumbs, and agenesis of the corpus callosum. ... Diagnosis Sajid and Copple (1968) found basilar impression (109500) as an associated feature in 2 brothers and suggested its usefulness in diagnosis. ... Schrander-Stumpel et al. (1990) noted that similar linkage of HSAS and the MASA syndrome (303350) to Xq28 and overlapping features of the two disorders suggested that they may be allelic. ... Okamoto et al. (1997) identified a mutation in the L1CAM gene (308840.0012) in a child with features of X-linked hydrocephalus (307000) who also had Hirschsprung disease and cleft palate.
    L1CAM, COL4A5, ENOPH1, FN1, CALM1, COL4A6, CAMKMT, KRIT1, CALM3, CALM2, COL4A4, COL4A3, COL4A1, MYO1E, NRCAM, OTC, ST14, CNTN6, CNTN5, AVPR2
    • Hydrocephalus Due To Congenital Stenosis Of Aqueduct Of Sylvius GARD
      Hydrocephalus due to congenital stenosis of aqueduct of sylvius (HSAS) is a form of L1 syndrome , which is an inherited disorder that primarily affects the nervous system. Males with HSAS are typically born with severe hydrocephalus and adducted thumbs (bent towards the palm). Other sign and symptoms of the condition include severe intellectual disability and spasticity. HSAS, like all forms of L1 syndrome, is caused by changes (mutations) in the L1CAM gene and is inherited in an X-linked recessive manner. Treatment is based on the signs and symptoms present in each person.
    • Hydrocephalus Due To Congenital Stenosis Of Aqueduct Of Sylvius OMIM
      Clinical Features In 2 sibships of a highly consanguineous Mexican kindred, Barros-Nunes and Rivas (1993) identified 3 males with hydrocephalus and 3 males with microcephaly.
    • Hydrocephalus With Stenosis Of The Aqueduct Of Sylvius Orphanet
      A congenital, X-linked, clinical subtype of L1 syndrome characterized by severe hydrocephalus often of prenatal onset, adducted thumbs, spasticity (mostly evidenced by brisk tendon reflexes and extensor plantar responses) and moderate to severe intellectual disability. This subtype represents the severe end of the L1 syndrome spectrum and is associated with poor prognosis.
  • ←
  • 1
  • 2
  • ...
  • 247
  • 248
  • 249
  • 250
  • 251
  • 252
  • 253
  • ...
  • 490
  • 491
  • →

FindZebra

contact@findzebra.com